Introduction {#Sec1}
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Mammary-type myofibroblastoma is a rare, benign, soft tissue tumor which morphologically resembles its mammary counterpart. The lesion was first described in 1987 by Wargotz *et al*. \[[@CR1]\] as a distinctive, benign, mesenchymal tumor of the breast. The lesion is usually well-circumscribed, composed of haphazardly arranged fascicles of spindle-shaped cells admixed with interrupted adipocytes in a collagenous and myxoid background. The presence of coffee-bean shaped nuclear grooves, which was first described by Wargotz *et al*. \[[@CR1]\], is a cytological clue for diagnosis in fine-needle aspiration cytology smears \[[@CR2]\]. The most common immunohistochemical profile seen in these tumors is diffuse positivity for CD34 and desmin \[[@CR3]\]; however, more variable positivity has also been reported \[[@CR4]\]. This tumor is most often confused with spindle cell lipoma, as both are spindle cell neoplasms, both are positive for CD34, and in addition at the molecular level, both reveal similar loss of genetic material from the 13q14 region \[[@CR3],[@CR5]\]. The standard management is surgical removal. Malignant behavior or recurrence has not been described.

A review of the literature revealed a total 20 cases of extra-mammary myofibroblastoma described to date, with a slightly male predilection \[[@CR3],[@CR5]-[@CR13]\]. The largest size reported in the literature was 13cm in diameter, and the most common location was the inguinal area (Table [1](#Tab1){ref-type="table"}) \[[@CR3]\]. Here we report a case of mammary-type myofibroblastoma, which we believe is the largest case (34cm in largest diameter) described so far, in the right thigh of a 50-year-old man. The literature is also reviewed.Table 1**Summary of current and previous reported cases of mammary-type myofibroblastomaReportSex/ageTumor size and weightSiteGross description of mass**Current caseM/5034×28×22cm, 13KgRight thighFirm, well-circumscribed with yellow cut surface and focal myxoid changeMillo *et al*. \[[@CR11]\]F/465.3cmLiverSolid, non-encapsulated, fat-containing tumorKojima *et al*. \[[@CR10]\]M/793.5×3.5×2cmRight seminal vesicleSharply demarcated, white whorled, solid massWei and Zhu \[[@CR15]\]F/804×3.5×1cmLeft vulvaFirm, tan, nodular, well-circumscribed, un-encapsulated.Arsenovic *et al*. \[[@CR6]\]F/405.5×4×4cmRight buttockElastic, grayish white, well-circumscribed mass with solid, whorled cut surfaceZhang *et al*. \[[@CR14]\]F/405cm, 40gPerianalWell-circumscribed, encapsulated nodular mass with solid, yellow homogenous cut surfaceHox *et al*. \[[@CR9]\]F/456cmBehind mandibular angleWell-circumscribed, mobile and soft massDiwadkar and Barber \[[@CR8]\]F/563cmLeft vulvaDensely adherent to surrounding tissueScotti *et al*. \[[@CR13]\]M/369cmPopliteal fossaNodular, whitish, well-circumscribed, un-encapsulated mass.Mukonoweshuro *et al*. \[[@CR12]\]M/857cm, 149gLeft paratestisWell-circumscribed, apparently encapsulated, nodular mass with solid, whorled pale-gray cut surfaceMaggiani *et al*. \[[@CR5]\]M/37NGroinFirm and well-circumscribed mass.McMenamin and Fletcher \[[@CR3]\] (9 cases)M (7), F (2) (35--67)6cm (2--13)IA (3), AW (1), VW (1), MB (1), TA (1), BT(1), RG (1)Mostly firm and well-circumscribed, yellow-white mass with whorled cut surfaceAW, Abdominal wall; BT, Buttock; IA, Inguinal area; MB, Mid back; RG, Right groin; PA, Paratesticular area; VW, Vaginal wall.

Case presentation {#Sec2}
=================

A 50-year-old Pakistani man presented to a tertiary care hospital with a long-standing history of a mass in his right thigh. His physical examination revealed a huge bulging mass on the medial side of his right thigh. No inguinal or any other local lymphadenopathy was present. A clinical impression of the soft tissue sarcoma was made and surgical excision of the mass was planned. Peroperatively, the mass was circumscribed, encapsulated and well-demarcated from underlying muscles, with no invasion of underlying tissues. Upon gross examination, the mass was well-circumscribed, firm in consistency, and measured approximately 34×28×22cm and weighed approximately 13kg (Figure [1](#Fig1){ref-type="fig"}A). The cut surface showed a pale yellow appearance, with focal myxoid change and few areas of cystic degeneration. Neither necrosis nor hemorrhage was noted (Figure [1](#Fig1){ref-type="fig"}B).Figure 1Gross and low microscopic view of the mass. **(A)** Well-circumscribed, oval to round large mass, with smooth external surface. **(B)** Sectioning reveals yellow-white, myxoid cut surface with a whorled pattern, no necrosis or hemorrhage seen. **(C)** Low microscopic field shows a well-circumscribed, un-encapsulated mass. **(D)** Bland, short, spindle-shaped cell fascicles arranged haphazardly in a collagenous stoma.

The tumor was extensively sampled for microscopic examination. Histologically, the mass was composed of short spindle to oval-shaped cells in a haphazard arrangement of fascicles and sheets (Figure [1](#Fig1){ref-type="fig"}C,D). The cells had eosinophilic cytoplasm with indistinct cell borders and elongated nuclei with fine chromatin. Focal interspersed adipocytes are seen (Figure [2](#Fig2){ref-type="fig"}A). Nuclear grooves were noted in some cells (Figure [2](#Fig2){ref-type="fig"}B). Mitotic activity was scant and no atypical mitotic figures were found. No cytologic atypia or necrosis was noted. The stroma was composed of thick bundles of collagen with focal myxoid change and was surrounded by fatty tissue. However, the surrounding fatty tissue did not show lipoblasts or atypical adipocytes. It was revealed on immunohistochemistry that the neoplastic spindle-shaped cells showed strong positive expression for CD34 (Figure [2](#Fig2){ref-type="fig"}C), and patchy expression for desmin (Figure [2](#Fig2){ref-type="fig"}D). An immunohistochemical stain for the S-100 protein showed positive expression in the background adipocytes. However, the neoplastic cells were negative for CD10, alpha smooth muscle actin, STAT6 B-cell lymphoma 2 (Bcl 2) and epithelial membrane antigen (EMA).Figure 2High microscopic view and immunohistochemical finding of the mass. **(A)** In this microscopic view, interrupted adipocytes are seen in a collagenous background. **(B)** High-power view shows the cells with coffee-bean shaped intranuclear grooves. Immunohistochemical stains show diffuse positivity for **(C)** CD34, and multifocal patchy positivity for **(D)** desmin.

Discussion {#Sec3}
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Myofibroblastoma is a rare, benign, mesenchymal tumor of breast. An extra-mammary location is rare, and usually occurs along the embryonic milk-line, which extends from the mid-axilla to medial groin \[[@CR3]\]. Accessory breast tissue can also be present along this embryonic line. However, several cases outside of this embryonic line have been also reported \[[@CR3],[@CR6],[@CR9],[@CR13],[@CR14]\], which is difficult to explain on the basis of the embryonic milk-line concept.

A review of the 20 previously reported cases showed that mammary-type myofibroblastoma occurs at a relatively old age, with an average reported age of 52.5 years (range 35 to 85 years), and slight male predominance (M:F ratio = 1:0.7). Classically, these tumors are mostly slow growing, and form painless masses. The average reported tumor size was 5.5cm (range 2 to 13cm), and most of the reported tumors were small and discovered incidentally. Most cases were reported in the pelvic area: five cases in the inguinal area \[[@CR3],[@CR5]\], three cases in the vulva and vaginal wall \[[@CR3],[@CR8],[@CR15]\], two in the paratesticular area \[[@CR3],[@CR12]\], and two cases in the buttock \[[@CR3],[@CR6]\], followed by single cases reported in a seminal vesicle \[[@CR10]\], the perianal region \[[@CR14]\], and the suprapubic area \[[@CR3]\]. So far, five cases have been reported outside the pelvis, including cases in the mandibular region \[[@CR9]\], popliteal fossa \[[@CR13]\], abdominal wall \[[@CR3]\], liver \[[@CR11]\], and back (Table [1](#Tab1){ref-type="table"}) \[[@CR3]\]. Regardless of size or location, these lesions behaved in a benign fashion, with no recurrences or metastases after surgical excision reported so far.

The mammary-type myofibroblastomas described in the literature are well-circumscribed, un-encapsulated masses, consisting of spindle-shaped cells haphazardly arranged in fascicles of various sizes, along with bands of hyalinized thick collagen in the background. Intralesional fat lobules are also seen, and intranuclear grooves have been described \[[@CR1],[@CR2]\]. It has been revealed on immunohistochemistry that these lesions have positive expression for CD34 and desmin. We describe what, to the best of our knowledge, is the largest case of mammary-type myofibroblastoma (34cm in maximum dimension) reported so far, and is the first case reported in the medial side of the thigh.

For the proper diagnosis of mammary-type myofibroblastoma in soft tissue outside the milk-line, clinicopathologic correlation is needed. Clinically, these tumors present as slow growing, painless masses, without evidence of local lymphadenopathy, in middle-aged patients. Pathologically, careful gross examination is essential to detect the presence or absence of necrosis, a fibrotic component, hemorrhage, and so on. Extensive sectioning for microscopic examination is essential in order to rule out the presence of cellular atypia or mitosis. Positive expression for immunostaining for CD34 and desmin is helpful in reaching a correct diagnosis.

The importance of mammary-type myofibroblastoma, regardless of size or location, primarily lies in its definition as a distinctive benign neoplasm, which should not be confused with malignant soft tissue neoplasms, such as stromal sarcoma, undifferentiated pleomorphic sarcoma (malignant fibrous histiocytoma), spindle cell carcinoma, and so on \[[@CR1],[@CR13]\].

The differential diagnosis includes both benign and malignant neoplasms. It is most often confused with spindle cell lipoma; however, other benign lesions such as angiofibroma, angiomyofibroblastoma, soft tissue perineurioma, and nodular fasciitis should also be considered and excluded \[[@CR3]\]. Both spindle cell lipoma and mammary-type myofibroblastoma are morphologically similar benign neoplasms, composed of CD34-positive spindle cells admixed with mature adipose tissue, and both reveal loss of genetic material from the chromosome 13q14 region \[[@CR5]\]. In mammary-type myofibroblastoma, the background stroma is more prominent and hyalinized, and the adipose tissue component is less prominent than in spindle cell lipoma \[[@CR16]\]. Moreover, spindle cell lipoma does not stain for desmin, whereas mammary-type myofibroblastoma is always positive for this immunohistochemical marker.

Tumors with uncertain behavior, such as lipomatous hemangiopericytoma and solitary fibrous tumor, and malignant tumors, such as low-grade spindle cell liposarcoma, low-grade peripheral nerve sheath tumor, and dermatofibrosarcoma protuberans, should also be considered in the differential diagnosis. Most of these entities can be eliminated from consideration with careful attention to histologic features. Of those listed, solitary fibrous tumor histologically is perhaps the closest mimic of mammary-type myofibroblastoma. Solitary fibrous tumor has a more prominent hemangiopericytomatous vasculature, and is also immunohistochmically positive for signal transducer and activator of transcription 6 (STAT6) protein \[[@CR17]\].

Conclusions {#Sec4}
===========

Mammary-type myofibroblastoma of the soft tissue is a benign, soft tissue neoplasm, and no malignant behavior and/or recurrence after surgical resection has been described in the cases reported so far. As an extremely rare tumor, the correct diagnosis and prompt management is important, and requires careful clinical and pathological workup and extensive sectioning after surgical excision to demonstrate the presence or absence of necrosis, mitosis, or nuclear atypia, and thus rule out a malignant neoplasm.
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